Dr. Daniela Vergara, The upstream genes in the cannabinoid biochemical pathway

February 2023

Dr. Daniela Vergara is an evolutionary biologist, data analyst, educator, scientific writer, and public speaker. In addition to her multiple publications, she founded and directs a non-profit organization, the Agricultural Genomics Foundation (AGF; AgriculturalGenomics.org). AGF aims to make hemp and cannabinoid science available to a broad public. Vergara has been part of escientific teams at private companies including Steep Hill, Inc. who are a global leader in agricultural testing, and the biotech company Front Range Biosciences. Dr. Vergara recently joined the Harvest New York Extension Team from Cornell University as an ‘Emerging Crop Specialist’ to help hemp farmers with their crop.

Dr. Vergara’s scientific publications include the comparison of the cannabinoids by the federally produced Cannabis to that produced by the private market. These results were featured in news platforms such as The Atlantic, Science, and FiveThirtyEight. Recently, she published a comparison between the genome of these federally produced varieties to the genome of the varieties found in the private markets. Some of her other scientific publications are a compilation of the existing genomic tools available for Cannabis research that was featured in Science, and the maternally inherited genomes (chloroplast and mitochondria). Vergara has authored these publications along with collaborators from the private sector in the Cannabis industry as well as academics from several institutions worldwide.

Vergara is also an international consultant and policy advisor and has advised companies in the US and Latin America. Additionally, she has worked as an expert witness for multiple legal cases in the US and abroad. Dr. Vergara is a scientific writer in both Spanish and English and has translated her scientific work in Spanish for a broad public in Hispanic Countries.

Previous Webinars

Michael Petersen

Apr 15, 2026 11:00 AM Mountain Time

Trait Modifications in Cannabis Through Engineering and Editing

Michael Petersen has over 40 years of experience as a researcher and mentor in the plant biotech space. He worked for 10 years at Agracetus, a small startup in Wisconsin and then 20 years as a Senior Fellow with Monsanto. Mike stayed […]

Read More »

Francesca Filbey, PhD

Apr 9, 2026 01:00 PM Mountain Time

Understanding Cannabis Use Disorder Through Neuroimaging and Behavior

Francesca Filbey is a Professor and Director of the NeuroImaging of Reward Dynamics Laboratory at the Center for BrainHealth, School of Behavioral and Brain Sciences at The University of Texas at Dallas, and an Adjunct Associate Professor at the University of Texas […]

Read More »

Travis Higginbotham

March 25 at 11:00 AM (MDT)

Turning Science into Cash Flow. Crop production performance and ROI analysis driven by crop science.25

Travis Higginbitham is the Founder & CEO of Due Diligence Horticulture (DDH). He is a horticultural and operations executive with deep experience leading controlled-environment agriculture, cannabis, and ornamental production businesses through innovation, growth, transition, and turnaround. Mr. […]

Read More »

Dr. Yan Wang

12 March, 1:00 PM MST

Real-time and long-term effects of medical marijuana on older adults with chronic pain: Early findings from a prospective cohort study.

 

Yan Wang is an Associate Professor of Epidemiology at the University of Florida (UF). Her research interests focus on leveraging advanced technologies and methods (e.g., wearable sensors, ecological momentary assessment/EMA) to improve […]

Read More »

Igor Grant, M.D. and Thomas Marcotte, Ph.D.

Thursday, February 12th at 1:00 PM MST

The UC San Diego Center for Medicinal Cannabis Research: Some Findings

Igor Grant, MD is Distinguished Professor, and Director of the Center for Medicinal Cannabis Research (CMCR) at the University of California San Diego (UCSD). Established in 2000, the CMCR has been at the forefront of advancing science and policy […]

Read More »

Almut Winterstein, PhD.

Jan 8, 2026 01:00 PM Mountain Time

Clinical research priorities gleaned real-world use patterns: the MEdical Marijuana Outcomes Research repositorY (MEMORY)

Almut Winterstein is Distinguished Professor and the Dr. Robert and Barbara Crisafi Chair for Medication Safety in the Department of Pharmaceutical Outcomes and Policy and in the Department of Epidemiology, and the founding Director of the […]

Read More »